From the College of Medicine, State University of New York Upstate School of Medicine; the Departments of Surgery and Orthopedic Surgery, State University of New York Upstate Medical University; and the College of Medicine, St. George's School of Medicine.
Plast Reconstr Surg. 2020 Aug;146(2):390-397. doi: 10.1097/PRS.0000000000007026.
Panniculectomies are associated with high complication rates (43 to 70 percent), particularly in patients with obesity, smoking, and diabetes mellitus. Closed-incision negative-pressure therapy can be used postoperatively to support healing by promoting angiogenesis and decreasing tension. The authors hypothesized that using it with panniculectomies would minimize complications, and that a longer duration of therapy would not increase the incidence of complications. The authors also evaluated whether closed-incision negative-pressure therapy malfunction was associated with complications.
This retrospective, uncontrolled case series analyzed 91 patients who underwent panniculectomies managed with closed-incision negative-pressure therapy performed by a single surgeon from 2014 to 2018. Patients were followed for 6 months; therapy duration and malfunction were recorded. Patients were placed into therapy duration groups (2 to 7, 8 to 10, or >10 days). Complications managed conservatively were minor and major if they required intervention. Odds ratios were performed with 95 percent confidence intervals and p values.
Mean follow-up was 225.1 days and mean closed-incision negative-pressure therapy duration was 10.5 days. Major complications were reported in five patients (5.5 percent), infections in four (4.4 percent), dehiscence in two (2.2 percent), and seroma in four (4.4 percent). Patients with malfunction [n = 16 (17.6 percent)] were more likely to experience complications (OR, 3.3; p = 0.043). No significant increase in complications was found with therapy duration longer than 10 days, but potentially there is an increased risk of infection (OR, 4.0; p = 0.067).
Although high complication rates have been associated with panniculectomies, the authors' results show that low complication rates can be achieved with closed-incision negative-pressure therapy. Randomized controlled trials need to be conducted evaluating different therapy systems and the optimal duration of therapy with panniculectomies.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
皮瓣切除术的并发症发生率较高(43%至 70%),尤其是在肥胖、吸烟和糖尿病患者中。术后可采用封闭式切口负压治疗来促进血管生成和减少张力,从而支持愈合。作者假设,将其与皮瓣切除术联合使用可以将并发症最小化,且治疗时间的延长不会增加并发症的发生率。作者还评估了封闭式切口负压治疗故障是否与并发症有关。
这是一项回顾性、非对照的病例系列研究,分析了 2014 年至 2018 年期间由一位外科医生进行的 91 例皮瓣切除术患者,这些患者采用了封闭式切口负压治疗。对患者进行了 6 个月的随访;记录了治疗持续时间和故障情况。将患者分为治疗持续时间组(2-7 天、8-10 天或>10 天)。如果需要干预,经保守治疗的并发症为轻微并发症,而经治疗的并发症为严重并发症。采用 95%置信区间和 p 值进行比值比。
平均随访时间为 225.1 天,平均封闭式切口负压治疗时间为 10.5 天。5 例(5.5%)患者出现严重并发症,4 例(4.4%)出现感染,2 例(2.2%)出现裂开,4 例(4.4%)出现血清肿。出现故障的患者(n=16,17.6%)更有可能出现并发症(OR,3.3;p=0.043)。治疗时间超过 10 天并未发现并发症发生率显著增加,但感染风险可能增加(OR,4.0;p=0.067)。
尽管皮瓣切除术的并发症发生率较高,但作者的研究结果表明,采用封闭式切口负压治疗可以实现低并发症发生率。需要进行随机对照试验,评估不同的治疗系统和皮瓣切除术的最佳治疗持续时间。
临床问题/证据水平: 治疗性,IV 级。